News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Encore Therapeutics Inc. Reports Additional Proof of Concept Results on its Extended Release Ropivacaine Injectable Gel for Postoperative Pain Management


8/2/2007 1:12:26 PM

CARLSBAD, Calif.--(BUSINESS WIRE)--ETI today reported on two pre-clinical studies demonstrating that its intradermal extended release Ropivacaine gel formulation (ETI-211) has a markedly improved safety and pharmacokinetic (PK) profile when compared to the currently marketed ropivacaine solution formulation.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES